2012
DOI: 10.1016/j.drugalcdep.2011.11.011
|View full text |Cite
|
Sign up to set email alerts
|

Contingency management in substance abuse treatment: A structured review of the evidence for its transportability

Abstract: Aims Extant literature on contingency management (CM) transportability, or its transition from academia to community practice, is reviewed. The Consolidated Framework for Implementation Research (CFIR; Damschroder et al., 2009) guides the examination of this material. Methods PsychInfo and Medline database searches identified 27 publications, with reviewed reference lists garnering 22 others. These 49 sources were examined according to CFIR domains of the intervention, outer setting, inner setting, clinician… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
49
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
7
3

Relationship

2
8

Authors

Journals

citations
Cited by 64 publications
(52 citation statements)
references
References 86 publications
2
49
0
Order By: Relevance
“…An attribute of CM that should facilitate its community transportability is a capacity for contextual adaptation (Hartzler, Lash, & Roll, 2012). To that end, others may find it useful to amend details of the patient vignette in the HRQ-CM to better match particular features (i.e., target population, patient behavior, involved reinforcers) of local CM interventions they seek to monitor.…”
Section: Discussionmentioning
confidence: 99%
“…An attribute of CM that should facilitate its community transportability is a capacity for contextual adaptation (Hartzler, Lash, & Roll, 2012). To that end, others may find it useful to amend details of the patient vignette in the HRQ-CM to better match particular features (i.e., target population, patient behavior, involved reinforcers) of local CM interventions they seek to monitor.…”
Section: Discussionmentioning
confidence: 99%
“…CM procedures have been effectively applied to reduce the use of a number of substances (Hartzler et al 2012, Stitzer et al 2007), including cigarettes (Alessi et al 2004, Yi et al 2008), alcohol (Alessi & Petry 2013, Koffarnus et al 2011, Petry et al 2000), cocaine (Higgins et al 1993, Petry et al 2013), marijuana (Carroll et al 2012), and opiates (Bickel & Marsch 1999, Bickel et al 1999a, DeFulio & Silverman 2011, Silverman et al 1996). CM treatment is also associated with increases in quality of life in substance abusers (Petry et al 2007), and cost-effectiveness studies suggest that these interventions result in a net economic gain owing to their relative efficacy and the expense associated with treatment failures in substance-abusing populations (e.g., inpatient treatment, incarceration, increased health care utilization) (Olmstead et al 2012, Sindelar et al 2007).…”
Section: The Repair Of Reinforcer Pathologiesmentioning
confidence: 99%
“…A commonly stated question is, “who pays for the incentives?” 86 . Due to its efficacy and subsequent reductions in other healthcare costs (i.e., cost-effectiveness) 87 some government agencies, such as the Veterans Administration, and large insurance corporations have assumed the costs and begun widespread implementation.…”
Section: Contingency Management For Exercisementioning
confidence: 99%